Found: 3
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018
Temirbulatov I.I., Ivashchenko D.V., Rudykh Z.A., Popova N.V., Tayurskaya K.S., Chertovskikh Ya.V., Sychev D.A.
Introduction. Proton pump inhibitors (PPI) are widely spread as antisecretory drugs for a treatment of acid diseases, such as the gastric ulcer. Most of the proton pump inhibitors are inactivated in the liver by cytochromes P450 2C19 (CYP2C19) to the form of i…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Denisenko N.P., Sychev D.A., Sizova Zh.M., Kazakov R.E., Grachev A.V.
Introduction. Cytochrome P-450 2C19 is the main isoenzyme responsible for the metabolism of proton pump inhibitors, the main group of drugs for treating stomach and duodenal ulcer. There are genetic differences that affect the activity of this enzyme: there ar…
Research article2014
Mirzaev K.B., Sychev D.A., Andreev D.A.
Genetically determined diversity in the activity of enzymes regulating the biotransformation of drugs and xenobiotics - cytochrome P450 (CYP) is one of the main causes of interindividual differences in the response of pharmacotherapy. The objective of this rev…